Drug treatment of COVID-19 infection : Current Opinion in Pulmonary Medicine Drug treatment
of COVID-19 infection : Current Opinion in Pulmonary Medicine Log in or Register Subscribe to …

Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …

Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

Abstract The new coronavirus (COVID-19) was first detected in Wuhan city of China in
December 2019. Most patients infected with COVID-19 had clinical presentations of dry …

Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

SARS-CoV-2 (COVID-19) has been changing the world since December 2019. A
comprehensive search into many COVID-19 treatment guidelines was conducted and …

Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low,
mild to moderate COVID-19 may progress to severe or even critical stages in about one …

Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic is ongoing and many drugs
have been studied in clinical trials. From a pathophysiological perspective, anti‐viral drugs …